We further analyzed the expression of DRD2 distribution in molecular subtypes of EC based on molecular classification of endometrioid and serous carcinomas, and found high expression of DRD2 in serous-like copy-number high subtype when compared to the other subtypes (p = 0.005) as seen in Fig. 1e. This evidence concerns the gene DRD2 and serous adenocarcinoma.